Morgens Waterfall Vintiadis & Co’s Pfizer PFE Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,642	Closed	-$314K	–	58
2019 Q2	$314K	Sell	7,642 -6,060	-44%	-$241K	0.22%	52
2019 Q1	$552K	Hold	13,702	–	–	0.4%	46
2018 Q4	$567K	Hold	13,702	–	–	0.5%	46
2018 Q3	$573K	Hold	13,702	–	–	0.37%	49
2018 Q2	$472K	Hold	13,702	–	–	0.33%	53
2018 Q1	$461K	Buy	+13,702	New	+$471K	0.35%	49
2015 Q4	–	Sell	-121,210	Closed	-$3.61M	–	50
2015 Q3	$3.61M	Hold	121,210	–	–	1.99%	13
2015 Q2	$3.86M	Sell	121,210 -52,700	-30%	-$1.72M	2.43%	17
2015 Q1	$5.74M	Hold	173,910	–	–	3.68%	7
2014 Q4	$5.14M	Hold	173,910	–	–	2.87%	14
2014 Q3	$4.88M	Buy	+173,910	New	+$4.88M	3.42%	11

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's PFE Position: Q3 2019 in Review

Morgens Waterfall Vintiadis & Co sold out of Pfizer (PFE) in Q3 2019, closing a stake of 7,642 shares — an estimated $314K sold.

Morgens Waterfall Vintiadis & Co first reported a position in PFE in Q3 2014 and held it in 11 quarters. The position peaked at $5.74M in Q1 2015. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

Morgens Waterfall Vintiadis & Co reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
Morgens Waterfall Vintiadis & Co sold 7,642 Pfizer shares in Q3 2019, an estimated $314K.
Morgens Waterfall Vintiadis & Co first reported a position in Pfizer in Q3 2014 and held it in 11 quarters.
Morgens Waterfall Vintiadis & Co's Pfizer position peaked at $5.74M in Q1 2015.
2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q3 2019, filed 14 Nov 2019.